Understanding stakeholder important outcomes and perceptions of equity, acceptability and feasibility of a care model for haemophilia management in the US: a qualitative study. (July 2016)

• Record Type: Journal Article
• Authors: Lane, S. J.; Sholapur, N. S.; Yeung, C. H. T.; Iorio, A.; Heddle, N. M.; Sholzberg, M.; Pai, M.
• Is Part Of: Haemophilia. Volume 22(2016)Supplement 3
• Page Start: 23
• Page End: 30
• Publication Date: 2016-07
• Subjects: access to healthcare -- comprehensive care -- haemophilia -- health equity -- integrated care -- qualitative research; Hemophilia -- Periodicals; 616.1572005
• DOI: 10.1111/hae.13009
• Languages: English
• ISSNs: 1351-8216

Abstract

Abstract : Introduction: Care for persons with haemophilia (PWH) is most commonly delivered through the integrated care model used by Hemophilia Treatment Centers (HTCs). Although this model is widely accepted as the gold standard for the management of haemophilia; there is little evidence comparing different care models. Aim: We performed a qualitative study to gain insight into issues related to outcomes, acceptability, equity and feasibility of different care models operating in the US. Methods: We used a qualitative descriptive approach with semi‐structured interviews. Purposive sampling was used to recruit individuals with experience providing or receiving care for haemophilia in the US through either an integrated care centre, a specialty pharmacy or homecare company, or by a specialist in a non‐specialized centre. Persons with haemophilia, parents of PWH aged ≤18, healthcare providers, insurance company representatives and policy developers were invited to participate. Results and Conclusions: Twenty‐nine interviews were conducted with participants representing 18 US states. Participants in the study sample had experience receiving or providing care predominantly within an HTC setting. Integrated care at HTCs was highly acceptable to participants, who appreciated the value of specialized, expert care in a multidisciplinary team setting. Equity and feasibility issues were primarily related to health insurance and funding limitations. Additional research is required to document the impact of care on health and psychosocial outcomes and identify effective ways to facilitate equitable access to haemophilia treatment and care.